Anamnesis Bio
About
Anamnesis Bio is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. They leverage a deep understanding of disease mechanisms to create targeted therapies with the potential to significantly impact patient outcomes. Their approach aims to address unmet needs in conditions like Alzheimer's and Parkinson's.
Key facts
At-a-glance profile data
- Website
- anamnesisbio.com
- Headquarters
- Israel
- Founded
- 2023
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on anamnesisbio.com, last scanned 24 Aug 2026. Run your own scan
- Email provider
- Google Workspace
Add first review